Vor Biopharma (VOR) Earnings Date, Estimates & Call Transcripts $0.20 +0.00 (+2.46%) Closing price 04:00 PM EasternExtended Trading$0.20 +0.00 (+0.05%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Vor Biopharma Earnings Summary Vor Biopharma released Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.40, which hit analysts' consensus estimates of -$0.40. With a trailing EPS of -$1.51, Vor Biopharma's earnings are expected to grow next year, from ($1.42) to ($1.03) per share. Nov. 7 Earnings ResourcesNov. 7 Earnings ReportConsensus EPS (Nov. 7) -$0.40 Actual EPS (Nov. 7) -$0.40 Get Vor Biopharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vor Biopharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVOR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Vor Biopharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.24-$0.24-$0.24Q2 20251-$0.24-$0.24-$0.24Q3 20251-$0.23-$0.23-$0.23Q4 20251-$0.23-$0.23-$0.23 FY 2025 4 -$0.94 -$0.94 -$0.94 Q1 20261-$0.21-$0.21-$0.21Q2 20261-$0.21-$0.21-$0.21Q3 20261-$0.22-$0.22-$0.22Q4 20261-$0.20-$0.20-$0.20 Vor Biopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/7/2024--$0.40-$0.40--$0.40--8/8/2024--$0.41-$0.41--$0.41--5/9/2024Q1 2024-$0.37-$0.45 -$0.08-$0.45--3/20/2024Q4 2023-$0.49-$0.39+$0.10-$0.39--11/7/2023Q3 2023-$0.46-$0.49 -$0.03-$0.49--8/10/2023Q2 2023-$0.42-$0.45 -$0.03-$0.45-- Vor Biopharma Earnings - Frequently Asked Questions When did Vor Biopharma announce their last quarterly earnings? Vor Biopharma (NYSE:VOR) last announced its quarterly earning data on Thursday, November 7, 2024. Learn more on VOR's earnings history. Did Vor Biopharma beat their earnings estimates last quarter? In the previous quarter, Vor Biopharma (NYSE:VOR) reported ($0.40) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.40). Learn more on analysts' earnings estimate vs. VOR's actual earnings. What is Vor Biopharma's EPS forecast for next year? Vor Biopharma's earnings are expected to grow from ($1.42) per share to ($1.03) per share in the next year. More Earnings Resources from MarketBeat Related Companies IMUX Earnings Date CHRS Earnings Date ORMP Earnings Date XBIT Earnings Date ZNTL Earnings Date SNTI Earnings Date ANRO Earnings Date MIST Earnings Date CLLS Earnings Date GALT Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles e.l.f. Beauty Sees Record Surge After Earnings, Rhode DealCrowdStrike Stock Slips: Analyst Downgrades Before Earnings Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsAdvance Auto Parts: Did Earnings Defuse Tariff Concerns?Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the Stock This page (NYSE:VOR) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vor Biopharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vor Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
